ID   PTPRB_HUMAN             Reviewed;        1997 AA.
AC   P23467; B7ZKS8; B7ZKT0; C9JX87; F5H3G6; Q14D85; Q3MIV7;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase beta;
DE            Short=Protein-tyrosine phosphatase beta;
DE            Short=R-PTP-beta;
DE            EC=3.1.3.48;
DE   AltName: Full=Vascular endothelial protein tyrosine phosphatase;
DE            Short=VE-PTP;
DE   Flags: Precursor;
GN   Name=PTPRB; Synonyms=PTPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LYS-94 AND
RP   GLY-127.
RC   TISSUE=Placenta;
RX   PubMed=2170109;
RA   Krueger N.X., Streuli M., Saito H.;
RT   "Structural diversity and evolution of human receptor-like protein
RT   tyrosine phosphatases.";
RL   EMBO J. 9:3241-3252(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4), AND
RP   VARIANT LYS-94.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=19116766; DOI=10.1007/s10456-008-9126-0;
RA   Yacyshyn O.K., Lai P.F.H., Forse K., Teichert-Kuliszewska K.,
RA   Jurasz P., Stewart D.J.;
RT   "Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in
RT   human endothelial cells.";
RL   Angiogenesis 12:25-33(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=19136612; DOI=10.1096/fj.08-123810;
RA   Mellberg S., Dimberg A., Bahram F., Hayashi M., Rennel E., Ameur A.,
RA   Westholm J.O., Larsson E., Lindahl P., Cross M.J., Claesson-Welsh L.;
RT   "Transcriptional profiling reveals a critical role for tyrosine
RT   phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial
RT   cell morphogenesis.";
RL   FASEB J. 23:1490-1502(2009).
RN   [9]
RP   INTERACTION WITH TEK.
RX   PubMed=19451274; DOI=10.1083/jcb.200811159;
RA   Winderlich M., Keller L., Cagna G., Broermann A., Kamenyeva O.,
RA   Kiefer F., Deutsch U., Nottebaum A.F., Vestweber D.;
RT   "VE-PTP controls blood vessel development by balancing Tie-2
RT   activity.";
RL   J. Cell Biol. 185:657-671(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 1676-1965 IN COMPLEX WITH
RP   INHIBITOR SULFAMIC ACID, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=17139078; DOI=10.1107/S0907444906037784;
RA   Evdokimov A.G., Pokross M., Walter R., Mekel M., Cox B., Li C.,
RA   Bechard R., Genbauffe F., Andrews R., Diven C., Howard B., Rastogi V.,
RA   Gray J., Maier M., Peters K.G.;
RT   "Engineering the catalytic domain of human protein tyrosine
RT   phosphatase beta for structure-based drug discovery.";
RL   Acta Crystallogr. D 62:1435-1445(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1662-1973 IN COMPLEX WITH
RP   INHIBITOR SULFAMIC ACID.
RX   PubMed=16759857; DOI=10.1016/j.bmcl.2006.05.074;
RA   Amarasinghe K.K.D., Evdokimov A.G., Xu K., Clark C.M., Maier M.B.,
RA   Srivastava A., Colson A.-O., Gerwe G.S., Stake G.E., Howard B.W.,
RA   Pokross M.E., Gray J.L., Peters K.G.;
RT   "Design and synthesis of potent, non-peptidic inhibitors of
RT   HPTPbeta.";
RL   Bioorg. Med. Chem. Lett. 16:4252-4256(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1686-1971.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein
RT   tyrosine phosphatome.";
RL   Cell 136:352-363(2009).
CC   -!- FUNCTION: Plays an important role in blood vessel remodeling and
CC       angiogenesis. Not necessary for the initial formation of blood
CC       vessels, but is essential for their maintenance and remodeling.
CC       Can induce dephosphorylation of TEK/TIE2, CDH5/VE-cadherin and
CC       KDR/VEGFR-2. Regulates angiopoietin-TIE2 signaling in endothelial
CC       cells. Acts as a negative regulator of TIE2, and controls TIE2
CC       driven endothelial cell proliferation, which in turn affects blood
CC       vessel remodeling during embryonic development and determines
CC       blood vessel size during perinatal growth. Essential for the
CC       maintenance of endothelial cell contact integrity and for the
CC       adhesive function of VE-cadherin in endothelial cells and this
CC       requires the presence of plakoglobin (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:19116766,
CC       ECO:0000269|PubMed:19136612}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- SUBUNIT: Monomer. Interacts with TEK (PubMed:19451274). Interacts
CC       via fibronectin type-III 17 domain with CDH5. Detected in a
CC       complex with CNTN1 and NRCAM (By similarity). Interacts
CC       (phosphorylated form) with FYN and GRB2 (By similarity).
CC       {ECO:0000250|UniProtKB:B2RU80, ECO:0000269|PubMed:19451274}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-1265766, EBI-641062;
CC       P10912:GHR; NbExp=3; IntAct=EBI-1265766, EBI-286316;
CC       P27361:MAPK3; NbExp=2; IntAct=EBI-1265766, EBI-73995;
CC       P08581:MET; NbExp=2; IntAct=EBI-1265766, EBI-1039152;
CC       Q02763:TEK; NbExp=3; IntAct=EBI-1265766, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P23467-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23467-2; Sequence=VSP_038521;
CC       Name=3;
CC         IsoId=P23467-3; Sequence=VSP_040484;
CC       Name=4;
CC         IsoId=P23467-4; Sequence=VSP_053944;
CC   -!- INDUCTION: Up-regulated by hypoxia. {ECO:0000269|PubMed:19116766}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54131; CAA38066.1; -; mRNA.
DR   EMBL; BX648245; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC025569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97254.1; -; Genomic_DNA.
DR   EMBL; BC101679; AAI01680.1; -; mRNA.
DR   EMBL; BC113463; AAI13464.1; -; mRNA.
DR   EMBL; BC143356; AAI43357.1; -; mRNA.
DR   EMBL; BC143360; AAI43361.1; -; mRNA.
DR   CCDS; CCDS44943.1; -. [P23467-3]
DR   CCDS; CCDS44944.1; -. [P23467-1]
DR   CCDS; CCDS55845.1; -. [P23467-2]
DR   CCDS; CCDS55846.1; -. [P23467-4]
DR   PIR; S12050; S12050.
DR   RefSeq; NP_001103224.1; NM_001109754.3. [P23467-3]
DR   RefSeq; NP_001193900.1; NM_001206971.2. [P23467-2]
DR   RefSeq; NP_001193901.1; NM_001206972.2. [P23467-4]
DR   RefSeq; NP_001317133.1; NM_001330204.1.
DR   RefSeq; NP_002828.3; NM_002837.5. [P23467-1]
DR   UniGene; Hs.201030; -.
DR   UniGene; Hs.434375; -.
DR   PDB; 2AHS; X-ray; 2.10 A; A/B=1686-1971.
DR   PDB; 2H02; X-ray; 2.30 A; A/B=1662-1973.
DR   PDB; 2H03; X-ray; 1.65 A; A=1676-1970.
DR   PDB; 2H04; X-ray; 2.30 A; A=1662-1973.
DR   PDB; 2HC1; X-ray; 1.30 A; A=1676-1965.
DR   PDB; 2HC2; X-ray; 1.40 A; A=1676-1965.
DR   PDB; 2I3R; X-ray; 1.85 A; A/B=1662-1973.
DR   PDB; 2I3U; X-ray; 1.85 A; A=1662-1973.
DR   PDB; 2I4E; X-ray; 1.75 A; A/B=1662-1973.
DR   PDB; 2I4G; X-ray; 1.65 A; A=1662-1973.
DR   PDB; 2I4H; X-ray; 2.15 A; A=1662-1973.
DR   PDB; 2I5X; X-ray; 1.70 A; A/B=1662-1973.
DR   PDBsum; 2AHS; -.
DR   PDBsum; 2H02; -.
DR   PDBsum; 2H03; -.
DR   PDBsum; 2H04; -.
DR   PDBsum; 2HC1; -.
DR   PDBsum; 2HC2; -.
DR   PDBsum; 2I3R; -.
DR   PDBsum; 2I3U; -.
DR   PDBsum; 2I4E; -.
DR   PDBsum; 2I4G; -.
DR   PDBsum; 2I4H; -.
DR   PDBsum; 2I5X; -.
DR   ProteinModelPortal; P23467; -.
DR   SMR; P23467; -.
DR   BioGrid; 111751; 8.
DR   IntAct; P23467; 27.
DR   MINT; MINT-1349770; -.
DR   STRING; 9606.ENSP00000334928; -.
DR   BindingDB; P23467; -.
DR   ChEMBL; CHEMBL2706; -.
DR   DrugBank; DB08678; (4-ETHYLPHENYL)SULFAMIC ACID.
DR   DrugBank; DB06989; {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID.
DR   GuidetoPHARMACOLOGY; 1851; -.
DR   DEPOD; P23467; -.
DR   iPTMnet; P23467; -.
DR   PhosphoSitePlus; P23467; -.
DR   BioMuta; PTPRB; -.
DR   DMDM; 317373518; -.
DR   MaxQB; P23467; -.
DR   PaxDb; P23467; -.
DR   PeptideAtlas; P23467; -.
DR   PRIDE; P23467; -.
DR   Ensembl; ENST00000261266; ENSP00000261266; ENSG00000127329. [P23467-1]
DR   Ensembl; ENST00000334414; ENSP00000334928; ENSG00000127329. [P23467-3]
DR   Ensembl; ENST00000538708; ENSP00000438927; ENSG00000127329. [P23467-4]
DR   Ensembl; ENST00000550857; ENSP00000447302; ENSG00000127329. [P23467-2]
DR   GeneID; 5787; -.
DR   KEGG; hsa:5787; -.
DR   UCSC; uc001swb.6; human. [P23467-1]
DR   CTD; 5787; -.
DR   DisGeNET; 5787; -.
DR   GeneCards; PTPRB; -.
DR   H-InvDB; HIX0017674; -.
DR   H-InvDB; HIX0037045; -.
DR   HGNC; HGNC:9665; PTPRB.
DR   HPA; CAB004782; -.
DR   HPA; HPA067868; -.
DR   MIM; 176882; gene.
DR   neXtProt; NX_P23467; -.
DR   OpenTargets; ENSG00000127329; -.
DR   PharmGKB; PA34010; -.
DR   eggNOG; KOG0791; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136384; -.
DR   HOGENOM; HOG000060224; -.
DR   HOVERGEN; HBG053759; -.
DR   InParanoid; P23467; -.
DR   KO; K05694; -.
DR   OMA; RVYQTNY; -.
DR   OrthoDB; EOG091G00JF; -.
DR   PhylomeDB; P23467; -.
DR   TreeFam; TF351926; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P23467; -.
DR   SIGNOR; P23467; -.
DR   ChiTaRS; PTPRB; human.
DR   EvolutionaryTrace; P23467; -.
DR   GeneWiki; PTPRB; -.
DR   GenomeRNAi; 5787; -.
DR   PRO; PR:P23467; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000127329; -.
DR   CleanEx; HS_PTPRB; -.
DR   ExpressionAtlas; P23467; baseline and differential.
DR   Genevisible; P23467; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   CDD; cd00063; FN3; 14.
DR   Gene3D; 2.60.40.10; -; 16.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 15.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 17.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF49265; SSF49265; 17.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50853; FN3; 12.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Angiogenesis; Complete proteome;
KW   Glycoprotein; Hydrolase; Membrane; Phosphoprotein; Polymorphism;
KW   Protein phosphatase; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1997       Receptor-type tyrosine-protein
FT                                phosphatase beta.
FT                                /FTId=PRO_0000025436.
FT   TOPO_DOM     23   1621       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1622   1642       Helical. {ECO:0000255}.
FT   TOPO_DOM   1643   1997       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       23    111       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      112    207       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      203    288       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      291    378       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      379    471       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      467    552       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      556    641       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      642    729       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      730    829       Fibronectin type-III 9.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      819    906       Fibronectin type-III 10.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      909   1001       Fibronectin type-III 11.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      995   1083       Fibronectin type-III 12.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1087   1175       Fibronectin type-III 13.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1173   1260       Fibronectin type-III 14.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1260   1356       Fibronectin type-III 15.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1357   1448       Fibronectin type-III 16.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1458   1554       Fibronectin type-III 17.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1703   1963       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1904   1910       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1904   1904       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044,
FT                                ECO:0000269|PubMed:17139078}.
FT   BINDING    1870   1870       Substrate.
FT   BINDING    1948   1948       Substrate. {ECO:0000250}.
FT   MOD_RES    1981   1981       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:B2RU80}.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    321    321       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    479    479       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    544    544       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    574    574       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    652    652       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    721    721       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    829    829       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1040   1040       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1096   1096       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1163   1163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1185   1185       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1212   1212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1274   1274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1367   1367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1470   1470       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1474   1474       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1518   1518       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     18       MLSHGAGLALWITLSLLQ -> MEAEFYMVILTCLIFRNSE
FT                                GFQIVHVQKQQCLFKNEKVVVGSCNRTIQNQQWMWTEDEKL
FT                                LHVKSALCLAISNSSRGPSRSAILDRCSQAPRWTCYDQEGF
FT                                LEVENASLFLQKQGSRVVVKKARKYLHSWMKIDVNKEGKLV
FT                                NESLCLQKAGLGAEVSVRSTRNTAPPQILTTFNAVPDGLVF
FT                                LIRNTTEAFIRNAAENYSQNSSERQHPNLHMTGITDTSWVL
FT                                STTQPFSSTTEE (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_040484.
FT   VAR_SEQ     377    466       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038521.
FT   VAR_SEQ     997   1086       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_053944.
FT   VARIANT      94     94       R -> K (in dbSNP:rs2252784).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2170109}.
FT                                /FTId=VAR_062251.
FT   VARIANT     127    127       S -> G (in dbSNP:rs2465811).
FT                                {ECO:0000269|PubMed:2170109}.
FT                                /FTId=VAR_062252.
FT   VARIANT     395    395       V -> A (in dbSNP:rs36027530).
FT                                /FTId=VAR_057135.
FT   VARIANT     415    415       D -> E (in dbSNP:rs2165627).
FT                                /FTId=VAR_057136.
FT   VARIANT     939    939       T -> M (in dbSNP:rs2304821).
FT                                /FTId=VAR_057137.
FT   VARIANT    1032   1032       T -> I (in dbSNP:rs34902691).
FT                                /FTId=VAR_057138.
FT   VARIANT    1934   1934       G -> A (in dbSNP:rs17226367).
FT                                /FTId=VAR_057139.
FT   CONFLICT    261    261       T -> S (in Ref. 1; CAA38066).
FT                                {ECO:0000305}.
FT   CONFLICT    666    666       L -> V (in Ref. 1; CAA38066).
FT                                {ECO:0000305}.
FT   CONFLICT    926    926       V -> A (in Ref. 2; BX648245).
FT                                {ECO:0000305}.
FT   CONFLICT   1559   1559       C -> R (in Ref. 1; CAA38066).
FT                                {ECO:0000305}.
FT   HELIX      1685   1687       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1688   1709       {ECO:0000244|PDB:2HC1}.
FT   TURN       1710   1716       {ECO:0000244|PDB:2HC1}.
FT   TURN       1720   1723       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1728   1730       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1740   1742       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1743   1745       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1753   1756       {ECO:0000244|PDB:2AHS}.
FT   STRAND     1757   1763       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1766   1769       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1771   1775       {ECO:0000244|PDB:2HC1}.
FT   TURN       1780   1782       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1783   1792       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1797   1800       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1804   1806       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1818   1821       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1823   1825       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1828   1837       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1839   1849       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1856   1865       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1870   1872       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1877   1893       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1894   1896       {ECO:0000244|PDB:2H03}.
FT   STRAND     1900   1903       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1905   1908       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1909   1926       {ECO:0000244|PDB:2HC1}.
FT   STRAND     1928   1930       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1932   1940       {ECO:0000244|PDB:2HC1}.
FT   HELIX      1950   1965       {ECO:0000244|PDB:2HC1}.
SQ   SEQUENCE   1997 AA;  224301 MW;  76E67B4A6109AA0F CRC64;
     MLSHGAGLAL WITLSLLQTG LAEPERCNFT LAESKASSHS VSIQWRILGS PCNFSLIYSS
     DTLGAALCPT FRIDNTTYGC NLQDLQAGTI YNFRIISLDE ERTVVLQTDP LPPARFGVSK
     EKTTSTSLHV WWTPSSGKVT SYEVQLFDEN NQKIQGVQIQ ESTSWNEYTF FNLTAGSKYN
     IAITAVSGGK RSFSVYTNGS TVPSPVKDIG ISTKANSLLI SWSHGSGNVE RYRLMLMDKG
     ILVHGGVVDK HATSYAFHGL TPGYLYNLTV MTEAAGLQNY RWKLVRTAPM EVSNLKVTND
     GSLTSLKVKW QRPPGNVDSY NITLSHKGTI KESRVLAPWI TETHFKELVP GRLYQVTVSC
     VSGELSAQKM AVGRTFPDKV ANLEANNNGR MRSLVVSWSP PAGDWEQYRI LLFNDSVVLL
     NITVGKEETQ YVMDDTGLVP GRQYEVEVIV ESGNLKNSER CQGRTVPLAV LQLRVKHANE
     TSLSIMWQTP VAEWEKYIIS LADRDLLLIH KSLSKDAKEF TFTDLVPGRK YMATVTSISG
     DLKNSSSVKG RTVPAQVTDL HVANQGMTSS LFTNWTQAQG DVEFYQVLLI HENVVIKNES
     ISSETSRYSF HSLKSGSLYS VVVTTVSGGI SSRQVVVEGR TVPSSVSGVT VNNSGRNDYL
     SVSWLLAPGD VDNYEVTLSH DGKVVQSLVI AKSVRECSFS SLTPGRLYTV TITTRSGKYE
     NHSFSQERTV PDKVQGVSVS NSARSDYLRV SWVHATGDFD HYEVTIKNKN NFIQTKSIPK
     SENECVFVQL VPGRLYSVTV TTKSGQYEAN EQGNGRTIPE PVKDLTLRNR STEDLHVTWS
     GANGDVDQYE IQLLFNDMKV FPPFHLVNTA TEYRFTSLTP GRQYKILVLT ISGDVQQSAF
     IEGFTVPSAV KNIHISPNGA TDSLTVNWTP GGGDVDSYTV SAFRHSQKVD SQTIPKHVFE
     HTFHRLEAGE QYQIMIASVS GSLKNQINVV GRTVPASVQG VIADNAYSSY SLIVSWQKAA
     GVAERYDILL LTENGILLRN TSEPATTKQH KFEDLTPGKK YKIQILTVSG GLFSKEAQTE
     GRTVPAAVTD LRITENSTRH LSFRWTASEG ELSWYNIFLY NPDGNLQERA QVDPLVQSFS
     FQNLLQGRMY KMVIVTHSGE LSNESFIFGR TVPASVSHLR GSNRNTTDSL WFNWSPASGD
     FDFYELILYN PNGTKKENWK DKDLTEWRFQ GLVPGRKYVL WVVTHSGDLS NKVTAESRTA
     PSPPSLMSFA DIANTSLAIT WKGPPDWTDY NDFELQWLPR DALTVFNPYN NRKSEGRIVY
     GLRPGRSYQF NVKTVSGDSW KTYSKPIFGS VRTKPDKIQN LHCRPQNSTA IACSWIPPDS
     DFDGYSIECR KMDTQEVEFS RKLEKEKSLL NIMMLVPHKR YLVSIKVQSA GMTSEVVEDS
     TITMIDRPPP PPPHIRVNEK DVLISKSSIN FTVNCSWFSD TNGAVKYFTV VVREADGSDE
     LKPEQQHPLP SYLEYRHNAS IRVYQTNYFA SKCAENPNSN SKSFNIKLGA EMESLGGKCD
     PTQQKFCDGP LKPHTAYRIS IRAFTQLFDE DLKEFTKPLY SDTFFSLPIT TESEPLFGAI
     EGVSAGLFLI GMLVAVVALL ICRQKVSHGR ERPSARLSIR RDRPLSVHLN LGQKGNRKTS
     CPIKINQFEG HFMKLQADSN YLLSKEYEEL KDVGRNQSCD IALLPENRGK NRYNNILPYD
     ATRVKLSNVD DDPCSDYINA SYIPGNNFRR EYIVTQGPLP GTKDDFWKMV WEQNVHNIVM
     VTQCVEKGRV KCDHYWPADQ DSLYYGDLIL QMLSESVLPE WTIREFKICG EEQLDAHRLI
     RHFHYTVWPD HGVPETTQSL IQFVRTVRDY INRSPGAGPT VVHCSAGVGR TGTFIALDRI
     LQQLDSKDSV DIYGAVHDLR LHRVHMVQTE CQYVYLHQCV RDVLRARKLR SEQENPLFPI
     YENVNPEYHR DPVYSRH
//
